Search Results 3261-3270 of 26215 for oral

  1. National Kidney Month Archives - Mayo Clinic News Network

    ... oral health for children. And Dr. Dawn Davis, a Mayo Clinic dermatologist, explains the importance of sunscreen to protect against sun damage. The post ...

  2. Short Bowel Syndrome and Teduglutide VS Placebo - Mayo Clinic

    Diuretics and oral rehydration solutions will be required to be stable for ≥4 weeks prior to baseline evaluations and remain stable during the study.

  3. Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

    ... oral antihypertensives as so judged by the treating physician; Known dihydropyrimidine dehydrogenase (DPD) deficiency; Impairment of GI function or GI disease ...

  4. Bronchiolitis - Diagnosis and treatment - Mayo Clinic

    Oral corticosteroid medicines and pounding on the chest to loosen mucus, a treatment called chest physiotherapy, have not been shown to be effective for ...

  5. A Study to Evaluate Lamprene (Clofazimine) to Treat Non-Tuberculous Mycobacterial (NTM) Infections - Mayo Clinic

    ... oral or injected or implanted hormonal contraception or intra-uterine device or with spermicidal foam/gel/film/ cream/vaginal suppository;; Use of oral ...

  6. A Study to Assess the Feasibility of Combining Clinically- indicated MitraClip Transcatheter Mitral Valve Repair (TMVR) and Watchman Left Atrial Appendage Occlusion (LAAO)

    The patient is eligible for short-term oral anticoagulation therapy with Warfarin or a direct oral anticoagulant. The patient or legal representative is ...

  7. A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors - Mayo Clinic

    Background regimen for UC may include oral 5-aminosalicylic acid (5-ASA), oral corticosteroids, budesonide multi-matrix system (MMX), probiotics ...

  8. MBI Response toTam - Mayo Clinic

    Hormonal contraception (oral, transdermal, implanted, or injected formulations) Hormonal IUDs are allowed; Selective estrogen receptor modulators (tamoxifen ...

  9. An Extension of a Previous Study Evaluating the Use of SER-109 to Prevent Recurrent Clostridium Difficile Infections - Mayo Clinic

    Antibiotic regimen (for the most recent CDI episode) should be14 days of oral vancomycin (125 mg, q6h) or 10 days of oral fidaxomicin (200 mg, q12h) with ...

  10. Publications - Michael M. Cutrer, M.D. - Mayo Clinic

    MAP0004, orally inhaled dihydroergotamine for acute treatment of ... Priorities for triptan treatment attributes and the implications for selecting an oral ...